Unlock stock picks and a broker-level newsfeed that powers Wall Street.

TSXV CAD

NAVCO Pharmaceuticals Inc. (NAV.V)

0.0050
0.0000
(0.00%)
At close: April 30 at 12:59:15 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
NameTitlePayExercisedYear Born
Mr. Geoffrey Lee Chief Executive Officer 62.77k -- --
Mr. Christopher R. Cooper Chief Financial Officer 31.6k -- 1971
Mr. Marek Jasinski COO & Director 72k -- 1977
Mr. Thomas Jusdanis Corporate Secretary & Independent Director 55.53k -- 1958

NAVCO Pharmaceuticals Inc.

5205 Harvester Road
Unit 1
Burlington, ON L7L 6B5
Canada
https://navcopharma.com
Sector: 
Healthcare

Description

NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives industries to combat microorganisms, such as viruses and bacteria. NAVCO Pharmaceuticals Inc. is headquartered in Burlington, Canada.

Corporate Governance

NAVCO Pharmaceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers